Sleeve gastrectomy and gastric bypass have helped millions — but long-term studies reveal important limitations. Here's what patients should know, and why newer procedures like SASJ are gaining ground.
For years, sleeve gastrectomy (removing most of the stomach to create a small tube) and Roux-en-Y gastric bypass (RYGB) (shrinking the stomach and rerouting the intestines) have been the two most common weight loss surgeries worldwide. Both produce real, meaningful results for many patients.
But as 10-year follow-up data have accumulated, a clearer picture has emerged: both procedures carry significant long-term downsides that don't always get the attention they deserve. Weight regain, severe acid reflux, intestinal complications, nutritional deficiencies, and the need for second surgeries are not rare outliers — they appear consistently across large, rigorous studies.
This page explains those limitations in plain terms, and introduces the next generation of procedures — OAGB, SASJ, and SASI — designed to deliver the benefits while reducing the long-term burden.
The sleeve became the world's most popular bariatric operation before long-term data were available. Now that 10-year results exist, the picture is more concerning than early figures suggested.
Turning the stomach into a narrow tube creates high pressure that pushes stomach acid upward. Over time, many sleeve patients develop severe, hard-to-treat acid reflux (heartburn) — and some develop a pre-cancerous condition called Barrett's esophagus.
The landmark SLEEVEPASS trial — the largest randomized study comparing sleeve to bypass with 10-year follow-up — found that esophageal inflammation was nearly five times more common after sleeve than after bypass (31% vs. 7%). And 21% of sleeve patients needed reoperation by year 10, most commonly to convert to a gastric bypass — specifically to treat uncontrolled reflux.
The sleeve works purely by limiting stomach size. Without changing gut hormones, the effect can fade. At 10+ years, the average total weight loss was only 24.4%, and about 20% of patients regained enough weight to require revision surgery. Diabetes improvement was also modest — only 45.6% of diabetic patients achieved lasting remission.
When a sleeve fails — due to reflux, weight regain, or esophageal damage — the most common fix is converting to a gastric bypass. This means some patients end up going through the risks of surgery twice. Choosing the right procedure from the start could spare these patients from a second operation.
"Despite its growing success, there is ongoing debate about long-term results of sleeve gastrectomy — particularly regarding durable effectiveness and the risk of Barrett's esophagus from de novo reflux." — Vitiello et al., Obesity Surgery, 2023
Gastric bypass is often called the "gold standard" because it produces greater weight loss and better diabetes outcomes than the sleeve. But its complexity comes with a distinct set of long-term risks that are sometimes underemphasized.
The way RYGB rearranges the bowel leaves several small gaps where a loop of intestine can slip through and become trapped — a condition called internal hernia. When this happens, the bowel can lose its blood supply quickly and require emergency surgery. It can occur years or even decades after the original operation, often with no warning signs. The cumulative lifetime risk — estimated at 3–5% — is clinically meaningful.
Gastric bypass reroutes food away from the duodenum and upper small intestine — the main absorption site for iron, calcium, vitamin D, vitamin B12, and folate. Patients must take supplements for the rest of their lives and have regular blood tests. Those who don't keep up face anemia, bone loss, nerve damage, and other serious complications.
Two surgical connections mean two potential sites for ulcers, leaks, and narrowing. Ulcers at the stomach-bowel connection occur in 1–16% of patients and can be difficult to treat. The portion of the original stomach left behind in RYGB also cannot be reached by a standard endoscope — a significant concern in East Asia, where stomach cancer rates are higher.
| Outcome (10-year data) | Sleeve | Gastric Bypass (RYGB) |
|---|---|---|
| Average weight loss | 43.5% excess weight | 50.7% excess weight |
| Diabetes remission rate | 26% | 33% |
| High blood pressure improvement | 8% | 24% |
| Esophageal inflammation rate | 31% | 7% |
| Need for second surgery | 15.7% | 18.5% |
| Intestinal herniation risk | Low | Meaningful lifetime risk |
| Nutritional supplement needs | Modest | Lifelong, multiple types |
| Full stomach scope access | Yes (no remnant) | Remnant cannot be scoped |
Source: SLEEVEPASS RCT, n=240, 10-year follow-up (JAMA Surgery, 2022).
The limitations of sleeve and bypass have driven surgeons to develop a new class of procedures. The core idea: shrink the stomach first, then add a single new connection to create two food pathways. This delivers the metabolic power of a bypass with just one surgical connection (versus two in RYGB), and avoids the reflux problem of the sleeve.
OAGB creates a long, narrow stomach pouch and connects it to a loop of small intestine with a single connection. It achieves weight loss comparable to or better than RYGB, takes less time to perform, and is now endorsed by the American Society for Metabolic and Bariatric Surgery (ASMBS). The theoretical concern about bile flowing into the stomach occurs in some patients but is generally manageable.
Developed and refined in Taiwan, SASJ combines a sleeve gastrectomy with a single connection to the jejunum (the middle section of the small intestine). Food travels two routes — some goes the normal way through the duodenum, and some takes a shortcut — triggering powerful gut hormones that improve metabolism. The jejunal connection position is carefully chosen to preserve at least 350 cm of absorptive intestine, keeping nutritional risk low.
A Taiwanese multi-center study of 1,479 patients (770 SASJ vs. 709 sleeve) found SASJ achieved significantly greater weight loss at 2 years (34.0% vs. 30.1% total weight loss, P < 0.001), with an 88.5% diabetes remission rate. Blood hemoglobin and protein levels stayed within normal range. The 30-day readmission rate was 1.0% — the same as sleeve.
SASJ also preserves access to the duodenum for scopes and bile duct procedures, eliminates the leftover stomach pouch (important for stomach cancer surveillance in Asia), and avoids the gaps that cause internal hernia in bypass — substantially reducing that risk.
SASI connects the lower sleeve to the ileum (the end section of the small intestine), creating an even stronger gut hormone response. It achieves powerful diabetes control — one study found complete diabetes resolution in all patients within 6 months. It is simpler than RYGB and preserves the natural stomach outlet and duodenal passage, with no blind-end bowel loop.
SASI carries a higher malnutrition risk if the connection is placed too far down the intestine. Careful patient selection and close nutritional follow-up are essential. SASJ was developed in part to address this concern by moving the connection to a safer location in the jejunum.
A 2026 meta-analysis (Jin et al., Updates in Surgery) combined 20 comparative studies and found:
Sleeve gastrectomy and gastric bypass remain effective procedures that have transformed the lives of millions. But the long-term evidence is equally clear: both carry significant trade-offs. The sleeve leads to reflux in a large proportion of patients. The bypass requires lifelong supplementation and carries a meaningful risk of bowel complications.
OAGB, SASJ, and SASI are not experimental novelties — they are backed by multi-center studies, systematic reviews, and randomized trial-level data. They offer a better overall package: durable weight loss, metabolic improvement, reflux control, nutritional safety, and a simpler surgical design.
There is no single right answer for every patient. The choice depends on your health profile, diabetes severity, reflux history, and personal preferences. We welcome you to schedule a consultation to discuss which option is best for you.
Consultation
Our team at Kaohsiung Chang Gung Weight Management Center provides a comprehensive pre-operative evaluation tailored to your health profile and goals.